Amantadine Hydrochloride Patent Expiration
Amantadine Hydrochloride is used for managing motor complications in patients with Parkinson's disease receiving levodopa-based therapy. It was first introduced by Endo Pharmaceuticals Inc
Amantadine Hydrochloride Patents
Given below is the list of patents protecting Amantadine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Gocovri | US11065213 | Amantadine compositions and preparations thereof | Aug 23, 2038 | Supernus Pharms |
Gocovri | US11077073 | Methods of using amantadine compositions | Aug 23, 2038 | Supernus Pharms |
Osmolex Er | US10213393 | Composition and method for treating neurological disease | Feb 15, 2038 | Supernus Pharms |
Osmolex Er | US10213394 | Composition and method for treating neurological disease | Feb 15, 2038 | Supernus Pharms |
Osmolex Er | US10500170 | Composition and method for treating neurological disease | Feb 15, 2038 | Supernus Pharms |
Osmolex Er | US10500171 | Composition and method for treating neurological disease | Feb 15, 2038 | Supernus Pharms |
Osmolex Er | US10500172 | Composition and method for treating neurological disease | Feb 15, 2038 | Supernus Pharms |
Osmolex Er | US10512617 | Composition and method for treating neurological disease | Feb 15, 2038 | Supernus Pharms |
Osmolex Er | US11890261 | Composition and method for treating neurological disease | Feb 15, 2038 | Supernus Pharms |
Gocovri | US10154971 | Methods of administering amantadine | Dec 04, 2034 | Supernus Pharms |
Gocovri | US10646456 | Methods of administering amantadine | Jun 17, 2034 | Supernus Pharms |
Gocovri | US11903908 | Methods of administering amantadine | Jun 17, 2034 | Supernus Pharms |
Gocovri | US11197835 | Method of administering amantadine prior to a sleep period | Dec 02, 2030 | Supernus Pharms |
Gocovri | US8741343 | Method of administering amantadine prior to a sleep period | Dec 02, 2030 | Supernus Pharms |
Gocovri | US9867791 | Method of administering amantadine prior to a sleep period | Dec 02, 2030 | Supernus Pharms |
Gocovri | US9867792 | Method of administering amantadine prior to a sleep period | Dec 02, 2030 | Supernus Pharms |
Gocovri | US9867793 | Method of administering amantadine prior to a sleep period | Dec 02, 2030 | Supernus Pharms |
Gocovri | US9877933 | Method of administering amantadine prior to a sleep period | Dec 02, 2030 | Supernus Pharms |
Osmolex Er | US8252331 | Osmotic device containing amantadine and an osmotic salt | Mar 13, 2030 | Supernus Pharms |
Gocovri | US8389578 | Composition and method for treating neurological disease | Jan 22, 2028 | Supernus Pharms |
Osmolex Er | US8389578 | Composition and method for treating neurological disease | Jan 22, 2028 | Supernus Pharms |
Osmolex Er | US8574626 | Osmotic device containing amantadine and an osmotic salt | Nov 28, 2025 | Supernus Pharms |
Gocovri | US8796337 | Composition and method for treating neurological disease | Nov 23, 2025 | Supernus Pharms |
Gocovri | US8889740 | Composition and method for treating neurological disease | Nov 23, 2025 | Supernus Pharms |
Gocovri | US8895614 | Composition and method for treating neurological disease | Nov 23, 2025 | Supernus Pharms |
Gocovri | US8895615 | Composition and method for treating neurological disease | Nov 23, 2025 | Supernus Pharms |
Gocovri | US8895616 | Composition and method for treating neurological disease | Nov 23, 2025 | Supernus Pharms |
Gocovri | US8895617 | Composition and method for treating neurological disease | Nov 23, 2025 | Supernus Pharms |
Gocovri | US8895618 | Composition and method for treating neurological disease | Nov 23, 2025 | Supernus Pharms |
Osmolex Er | US8796337 | Composition and method for treating neurological disease | Nov 23, 2025 | Supernus Pharms |
Osmolex Er | US8889740 | Composition and method for treating neurological disease | Nov 23, 2025 | Supernus Pharms |
Osmolex Er | US8895614 | Composition and method for treating neurological disease | Nov 23, 2025 | Supernus Pharms |
Osmolex Er | US8895615 | Composition and method for treating neurological disease | Nov 23, 2025 | Supernus Pharms |
Osmolex Er | US8895616 | Composition and method for treating neurological disease | Nov 23, 2025 | Supernus Pharms |
Osmolex Er | US8895617 | Composition and method for treating neurological disease | Nov 23, 2025 | Supernus Pharms |
Osmolex Er | US8895618 | Composition and method for treating neurological disease | Nov 23, 2025 | Supernus Pharms |
Osmolex Er | US8987333 | Composition and method for treating neurological disease | Nov 23, 2025 | Supernus Pharms |
Osmolex Er | US9072697 | Composition and method for treating neurological disease | Nov 23, 2025 | Supernus Pharms |
Osmolex Er | USRE39069 | Multi-layered osmotic device |
May 29, 2018
(Expired) | Supernus Pharms |
Amantadine Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Amantadine Hydrochloride Generic API Manufacturers
Several generic applications have been filed for Amantadine Hydrochloride. The first generic version for Amantadine Hydrochloride was by Upsher Smith Laboratories Llc and was approved on Aug 5, 1986. And the latest generic version is by Zhejiang Jutai Pharmaceutical Co Ltd and was approved on Sep 26, 2024.
Given below is the list of companies who have filed for Amantadine Hydrochloride generic, along with the locations of their manufacturing plants worldwide.
1. ACTAVIS ELIZABETH
Actavis Elizabeth Llc has filed for 1 generic for Amantadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Actavis Elizabeth.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
100MG | capsule | Discontinued | ORAL | N/A | Feb 23, 2006 |
Manufacturing Plant Locations New
Actavis Elizabeth's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Actavis Elizabeth as present at those locations.
Country | City | Firm Name | ||
---|---|---|---|---|
United States |
|
2. ADAPTIS
Adaptis Pharma Private Ltd has filed for 1 generic for Amantadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Adaptis.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
100MG | tablet | Discontinued | ORAL | N/A | May 27, 2022 |
3. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 1 generic for Amantadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Alembic.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
100MG | tablet | Prescription | ORAL | AB | Oct 15, 2020 |
Manufacturing Plant Locations New
Alembic's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alembic as present at those locations.
Country | City | Firm Name | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
India |
|
4. ATHEM
Athem Holdings Llc has filed for 1 generic for Amantadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Athem.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
100MG | tablet | Prescription | ORAL | AB | Mar 10, 2020 |
5. AUROBINDO PHARMA USA
Aurobindo Pharma Usa Inc has filed for 1 generic for Amantadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Usa.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
50MG/5ML
(reference standard) | syrup | Prescription | ORAL | AA | Oct 28, 1994 |
Manufacturing Plant Locations New
Aurobindo Pharma Usa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Usa as present at those locations.
Country | City | Firm Name | ||
---|---|---|---|---|
United States |
|
6. BIONPHARMA
Bionpharma Inc has filed for 1 generic for Amantadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Bionpharma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
100MG
(reference standard) | capsule | Prescription | ORAL | AB | May 29, 2008 |
Manufacturing Plant Locations New
Bionpharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Bionpharma as present at those locations.
Country | City | Firm Name | ||
---|---|---|---|---|
United States |
|
7. CHARTWELL MOLECULAR
Chartwell Molecular Holdings Llc has filed for 1 generic for Amantadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Chartwell Molecular.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
100MG | capsule | Discontinued | ORAL | N/A | Jun 15, 2017 |
8. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 1 generic for Amantadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
50MG/5ML | syrup | Discontinued | ORAL | N/A | Sep 10, 2004 |
9. CMP PHARMA INC
Cmp Pharma Inc has filed for 1 generic for Amantadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Cmp Pharma Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
50MG/5ML | syrup | Discontinued | ORAL | N/A | Sep 11, 2002 |
Manufacturing Plant Locations New
Cmp Pharma Inc's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Cmp Pharma Inc as present at those locations.
Country | City | Firm Name | ||
---|---|---|---|---|
United States |
|
10. ELYSIUM
Elysium Pharmaceuticals Ltd has filed for 1 generic for Amantadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Elysium.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
50MG/5ML | syrup | Prescription | ORAL | AA | Aug 20, 2021 |
Manufacturing Plant Locations New
Elysium's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Elysium as present at those locations.
Country | City | Firm Name | ||
---|---|---|---|---|
India |
|
11. ENDO OPERATIONS
Endo Operations Ltd has filed for 1 generic for Amantadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Endo Operations.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
50MG/5ML | syrup | Discontinued | ORAL | N/A | Dec 12, 2006 |
12. G AND W LABS INC
G And W Laboratories Inc has filed for 1 generic for Amantadine Hydrochloride. Given below are the details of the strengths of this generic introduced by G And W Labs Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
50MG/5ML | syrup | Discontinued | ORAL | N/A | Oct 30, 1990 |
13. HERITAGE PHARMA
Heritage Pharma Labs Inc has filed for 1 generic for Amantadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Heritage Pharma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
100MG | capsule | Prescription | ORAL | AB | Jun 12, 2017 |
Manufacturing Plant Locations New
Heritage Pharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Heritage Pharma as present at those locations.
Country | City | Firm Name | ||||
---|---|---|---|---|---|---|
United States |
|
14. HUMANWELL PURACAP
Humanwell Puracap Pharmaceutical Wuhan Co Ltd has filed for 1 generic for Amantadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Humanwell Puracap.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
100MG | capsule | Prescription | ORAL | AB | Dec 20, 2022 |
Manufacturing Plant Locations New
Humanwell Puracap's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Humanwell Puracap as present at those locations.
Country | City | Firm Name | ||
---|---|---|---|---|
China |
|
15. INVAGEN PHARMS
Invagen Pharmaceuticals Inc has filed for 1 generic for Amantadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Invagen Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
100MG | tablet | Discontinued | ORAL | N/A | Jan 31, 2017 |
16. JUBILANT GENERICS
Jubilant Generics Ltd has filed for 1 generic for Amantadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Jubilant Generics.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
100MG | tablet | Discontinued | ORAL | N/A | Feb 7, 2018 |
Manufacturing Plant Locations New
Jubilant Generics's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Jubilant Generics as present at those locations.
Country | City | Firm Name | ||
---|---|---|---|---|
India |
|
17. PHARM ASSOC
Pharmaceutical Associates Inc has filed for 1 generic for Amantadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Pharm Assoc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
50MG/5ML
(reference standard) | syrup | Prescription | ORAL | AA | Jul 17, 1995 |
18. RISING
Rising Pharma Holdings Inc has filed for 1 generic for Amantadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Rising.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
100MG | capsule | Prescription | ORAL | AB | Mar 2, 2020 |
Manufacturing Plant Locations New
Rising's manufacturing plants are situated in 3 countries - United States, Mexico, India. Given below are the details of these plant locations as well as the firm names of Rising as present at those locations.
Country | City | Firm Name | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
United States |
| |||||||||||||||||||
Mexico |
| |||||||||||||||||||
India |
|
19. RUBICON
Rubicon Research Private Ltd has filed for 1 generic for Amantadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Rubicon.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
100MG | capsule | Prescription | ORAL | AB | May 21, 2020 |
Manufacturing Plant Locations New
Rubicon's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Rubicon as present at those locations.
Country | City | Firm Name | ||||
---|---|---|---|---|---|---|
United States |
| |||||
Canada |
| |||||
India |
|
20. SANDOZ
Sandoz Inc has filed for 1 generic for Amantadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Sandoz.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
100MG | capsule | Prescription | ORAL | AB | Feb 18, 1987 |
Manufacturing Plant Locations New
Sandoz's manufacturing plants are situated in 4 countries - Austria, United States, Spain, India. Given below are the details of these plant locations as well as the firm names of Sandoz as present at those locations.
Country | City | Firm Name | ||||
---|---|---|---|---|---|---|
Austria |
| |||||
United States |
| |||||
Spain |
| |||||
India |
|
21. SOLVAY
Solvay Pharmaceuticals has filed for 1 generic for Amantadine Hydrochloride. This 100mg version comes by the name SYMADINE. Given below are the details of the strengths of this generic introduced by Solvay.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
100MG | capsule | Discontinued | ORAL | N/A | Sep 4, 1986 |
Manufacturing Plant Locations New
Solvay's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Solvay as present at those locations.
Country | City | Firm Name | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
United States |
|
22. STRIDES PHARMA
Strides Pharma Global Pte Ltd has filed for 1 generic for Amantadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Strides Pharma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
100MG | capsule | Prescription | ORAL | AB | Feb 18, 2022 |
Manufacturing Plant Locations New
Strides Pharma's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Strides Pharma as present at those locations.
Country | City | Firm Name | ||||
---|---|---|---|---|---|---|
United States |
| |||||
India |
|
23. TEVA PHARMS
Teva Pharmaceuticals Usa has filed for 1 generic for Amantadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Teva Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
50MG/5ML | syrup | Discontinued | ORAL | N/A | Aug 23, 1991 |
24. UPSHER SMITH LABS
Upsher Smith Laboratories Llc has filed for 1 generic for Amantadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Upsher Smith Labs.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
100MG
(reference standard) | tablet | Prescription | ORAL | AB | Dec 16, 2002 |
25. WATSON LABS
Watson Laboratories Inc has filed for 1 generic for Amantadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Watson Labs.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
100MG | capsule | Discontinued | ORAL | N/A | Jan 21, 1987 |
26. WATSON LABS INC
Watson Laboratories Inc has filed for 1 generic for Amantadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Watson Labs Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
100MG | tablet | Prescription | ORAL | AB | Dec 15, 2016 |
27. XTTRIUM LABS INC
Xttrium Laboratories Inc has filed for 1 generic for Amantadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Xttrium Labs Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
50MG/5ML | syrup | Prescription | ORAL | AA | Dec 24, 1998 |
28. ZHEJIANG JUTAI PHARM
Zhejiang Jutai Pharmaceutical Co Ltd has filed for 1 generic for Amantadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Zhejiang Jutai Pharm.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
100MG | tablet | Prescription | ORAL | AB | Sep 26, 2024 |
29. ZYDUS
Zydus Worldwide Dmcc has filed for 1 generic for Amantadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Zydus.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 68.5MG BASE | capsule, extended release | Prescription | ORAL | AB | Aug 26, 2024 |
Manufacturing Plant Locations New
Zydus's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Zydus as present at those locations.
Country | City | Firm Name | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
India |
| |||||||||||||||||||||||
United States |
|
30. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 1 generic for Amantadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
100MG | capsule | Prescription | ORAL | AB | May 31, 2016 |